Navigation Links
American Society for Microbiology honors Caroline S. Harwood
Date:3/4/2010

The 2010 American Society for Microbiology (ASM) Procter & Gamble Award in Applied and Environmental Microbiology is being presented to Caroline S. Harwood, Ph.D., Gerald and Lyn Grinstein Professor of Microbiology, The University of Washington, Seattle, for being a leader in biodegradation. This award recognizes distinguished achievement in research and development in applied and environmental microbiology.

Harwood is internationally recognized for her discovery and characterization of the genes and enzymes in the pathway used for photosynthetic bacteria for the degradation of lignin components. The pathway discovered by Harwood is known to be the major route used by all anaerobic organisms for the degradation of aromatic compounds. It plays a major role in the degradation of environmental pollutants and the redistribution of carbon in nature. She led the genome sequencing effort on the photosynthetic bacterium, Rhodopseudomonas palustris and followed this with work on the development of a light-driven nitrogenase process for the production of hydrogen as a non-polluting energy source. Additionally, her lab was the first to establish the critical role that chemotaxis plays in the aerobic biodegradation of a wide range of aromatic environmental pollutants.

Currently, Harwood is working on biodegradation and signal transduction with the identification of a novel p-coumaroyl-homoserine lactone that accelerates the biodegradation of lignin compounds. This work in quorum sensing introduced the concept of interspecies signal transduction and places Harwood at the forefront of biodegradation, signal transduction, and biofuel research.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: